文献速递间质性肺疾病

经支气管肺冷冻活检诊断间质性肺疾病的准确性(COLDICE):前瞻性比较研究

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.
PubMed 文献 · Lancet Respir Med · 2019-09-29

COLDICE 是一项前瞻性多中心诊断准确性研究,纳入 65 例需组织病理评估的间质性肺疾病患者,在同一次麻醉下序贯行经支气管肺冷冻活检(TBLC)与外科肺活检(SLB),由设盲病理医师判读并在多学科讨论(MDD)中比较诊断一致性。TBLC 在 MDD 中高或确定诊断信心时与 SLB 诊断的一致率为 95%。

要点

  • TBLC 在 MDD 高或确定诊断信心的 39 例中,37 例(95%)与 SLB 诊断一致。
  • TBLC 相关轻中度气道出血发生于 14 例(22%),90 天死亡 1 例(2%)。

核心结论

  • TBLC 与 SLB 在组织病理判读和 MDD 诊断上均显示高度一致性,支持 TBLC 用于间质性肺疾病诊断流程。

研究设计与样本

  • COLDICE 为前瞻性、多中心诊断准确性研究,在澳大利亚 9 家三级医院开展。
  • 纳入 65 例 18-80 岁需组织病理评估的间质性肺疾病患者,同一次麻醉下序贯行 TBLC 与 SLB,样本编码后由设盲病理医师分析。
  • 主要终点为 TBLC 与 SLB 的组织病理特征一致性及 MDD 共识临床诊断一致性。

主要发现

  • TBLC 在 MDD 高或确定诊断信心的 39 例(60%)中,37 例(95%)与 SLB 诊断一致。
  • TBLC 低信心或无法分类的 26 例(40%)中,SLB 将 6 例(23%)重新分类为替代的高信心或确定 MDD 诊断。
  • TBLC 相关轻中度气道出血发生于 14 例(22%),90 天死亡 1 例(2%),死于特发性肺纤维化急性加重。

临床怎么用

  • TBLC 可作为间质性肺疾病组织取样的一种微创选择,尤其在 MDD 中能达到高或确定诊断信心时与 SLB 诊断高度一致。

局限性

  • 需进一步研究评估 TBLC 的安全性特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transbronchial lung cryobiopsy (TBLC) is a novel technique for sampling lung tissue for interstitial lung disease diagnosis. The aim of this study was to establish the diagnostic accuracy of TBLC compared with surgical lung biopsy (SLB), in the context of increasing use of TBLC in clinical practice as a less invasive biopsy technique. METHODS: COLDICE was a prospective, multicentre, diagnostic accuracy study investigating diagnostic agreement between TBLC and SLB, across nine Australian tertiary hospitals. Patients with interstitial lung disease aged between 18 and 80 years were eligible for inclusion if they required histopathological evaluation to aid diagnosis, after detailed baseline evaluation. After screening at a centralised multidisciplinary discussion (MDD), patients with interstitial lung disease referred for lung biopsy underwent sequential TBLC and SLB under one anaesthetic. Each tissue sample was assigned a number between 1 and 130, allocated in a computer-generated random sequence. Encoded biopsy samples were then analysed by masked pathologists. At subsequent MDD, de-identified cases were discussed twice with either TBLC or SLB along with clinical and radiological data, in random non-consecutive order. Co-primary endpoints were agreement of histopathological features in TBLC and SLB for patterns of definite or probable usual interstitial pneumonia, indeterminate for usual interstitial pneumonia, and alternative diagnosis; and for agreement of consensus clinical diagnosis using TBLC and SLB at MDD. Concordance and κ values were calculated for each primary endpoint. This study is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12615000718549. FINDINGS: Between March 15, 2016, and April 15, 2019, we enrolled 65 patients (31 [48%] men, 34 [52%] women; mean age 66·1 years [SD 9·3]; forced vital capacity 83·7% [SD 14·2]; diffusing capacity for carbon monoxide 63·4% [SD 12·8]). TBLC (7·1 mm, SD 1·9) and SLB (46·5 mm, 14·9) samples were each taken from two separate ipsilateral lobes. Histopathological agreement between TBLC and SLB was 70·8% (weighted κ 0·70, 95% CI 0·55-0·86); diagnostic agreement at MDD was 76·9% (κ 0·62, 0·47-0·78). For TBLC with high or definite diagnostic confidence at MDD (39 [60%] of 65 cases), 37 (95%) were concordant with SLB diagnoses. In the 26 (40%) of 65 cases with low-confidence or unclassifiable TBLC diagnoses, SLB reclassified six (23%) to alternative high-confidence or definite MDD diagnoses. Mild-moderate airway bleeding occurred in 14 (22%) patients due to TBLC. The 90-day mortality was 2% (one of 65 patients), following acute exacerbation of idiopathic pulmonary fibrosis. INTERPRETATION: High levels of agreement between TBLC and SLB for both histopathological interpretation and MDD diagnoses were shown. The TBLC MDD diagnoses made with high confidence were particularly reliable, showing excellent concordance with SLB MDD diagnoses. These data support the clinical utility of TBLC in interstitial lung disease diagnostic algorithms. Further studies investigating the safety profile of TBLC are needed. FUNDING: University of Sydney, Hunter Medical Research Institute, Erbe Elektromedizin, Medtronic, Cook Medical, Rymed, Karl-Storz, Zeiss, and Olympus.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Troy LK, Grainge C, Corte TJ, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2019. PMID: 31578168. doi:10.1016/S2213-2600(19)30342-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。